Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
KO-947
i
Other names:
KO-947, ARS-947
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(3)
News
Trials
Company:
Araxes Pharma, Kura Oncology
Drug class:
ERK inhibitor
Related drugs:
‹
SCH772984 (11)
ONC201 (5)
DEL-22379 (2)
AEZS-129 (1)
AEZS-134 (1)
CC-90003 (0)
bezisterim (0)
NSC311152 (0)
RG7842 (0)
SCH772984 (11)
ONC201 (5)
DEL-22379 (2)
AEZS-129 (1)
AEZS-134 (1)
CC-90003 (0)
bezisterim (0)
NSC311152 (0)
RG7842 (0)
›
Associations
(3)
News
Trials
VERI cancer hierarchy
Reset Filters
NRAS mutation
Non Small Cell Lung Cancer
NRAS mutation
Non Small Cell Lung Cancer
KO-947
Sensitive: C2 – Inclusion Criteria
KO-947
Sensitive
:
C2
KO-947
Sensitive: C2 – Inclusion Criteria
KO-947
Sensitive
:
C2
NRAS mutation
Melanoma
NRAS mutation
Melanoma
KO-947
Sensitive: D – Preclinical
KO-947
Sensitive
:
D
KO-947
Sensitive: D – Preclinical
KO-947
Sensitive
:
D
NRAS mutation
Pancreatic Cancer
NRAS mutation
Pancreatic Cancer
KO-947
Sensitive: D – Preclinical
KO-947
Sensitive
:
D
KO-947
Sensitive: D – Preclinical
KO-947
Sensitive
:
D
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login